The Montreal Heart Institute Research Centre is once again pushing the limits of knowledge in personalized medicine. A meta-analysis combining the results of several pharmacogenomic studies and involving over 40,000 research subjects now makes it possible to demonstrate a different response to statins according to the patient's gene profile.
High doses of fish oil supplements, rich in omega-3 fatty acids, do not reduce atrial fibrillation, a common type of irregular heartbeat in which the heart can beat as fast as 150 beats a minute. The results of the AFFORD trial led by the Montreal Heart Institute were published in the Journal of the American College of Cardiology on October 7th.
On March 25, as part of its 60th anniversary celebrations, the Montreal Heart Institute (MHI) honoured three of its builders: internationally renowned cardiologists Dr. Paul David, founder of the MHI, and Dr. Martial Bourassa, first director of the Research Centre, as well as Mr. J.-Louis Lévesque, philanthropist. The event was held at Maison Birks, a partner of the MHI's 60th anniversary celebrations.
